ANGLE ORD GBP0.10
Symbol: AGL
Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.
Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.
Invest in this share within an ISA, JISA, SIPP or Investment Account
Overview
Core Data
Latest Dividend Information
| Ex-Dividend Date | Unknown |
| Pay Date | Unknown |
| Total Dividends - Year to Date | 0 |
| Dividend Yield (%) | 0 |
Historical Data & Ratios
| Avg Volume Over 10 Days | 2.1429 |
| Market Cap (M) | 37.7842 |
| Price/Earnings (PE) | 0 |
| Earnings Per Share | -8.6 |
| Revenue Per Share | 0.0042 |
| Return on Equity % | -53.9500 |
1 Month Performance Chart
Broker View
Data shown is based on the past 75 days of broker views.
|
ActionBrokers |
Strong Buy1 |
Buy0 |
Neutral0 |
Sell0 |
Strong Sell0 |
|---|---|---|---|---|---|
| Brokers | 1 | 0 | 0 | 0 | 0 |
| Consensus |
ConsensusStrong Buy |
||||
Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.
Cost and Charges Information
This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product
Account Type
Annual charges
These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate
| Cost Category | % of Investment | lump sum costs |
|---|---|---|
Our annual fee
Our annual feeIncludes our platform fee at 0.35% per annum for Funds (up to £250,000) and Stocks & Shares (min £24 max £240), plus SIPP administration fee (if applicable, only charged if <£30,000 held) - see here |
0.35% | |
Dealing charges
Dealing chargesAny one-off commission charges associated with investing. Note that government taxes and levies are not included |
N/A | |
Product provider costs
Product provider costsProduct provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs |
N/A | N/A |
Total (£)
Total (£)Costs per annum displayed in monetary value |
||
Total (%)
Total (%)Costs per annum displayed as a percentage of investment value |
||
Cumulative effect of charges on your investment's return
This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges
| lump sum invested with an assumed growth rate of | 1 year | years |
|---|---|---|
What you might get back at with no charges applied
What you might get back at with no charges appliedThese are the illustrative values of a investment after growth and no costs applied at the end of the defined period |
||
Annual charges
Annual chargesThese are the annual costs based on an initial investment amount of assuming a net zero growth rate |
||
Effect of charges on return (%)
Effect of charges on return (%)These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate |
||
Effect of charges on return (£)
Effect of charges on return (£)These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate |
||
What you might get back at with charges applied
What you might get back at with charges appliedThese are the illustrative values of a investment after growth and costs at the end of the defined period |
This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use
Charts
Company
Business Summary
ANGLE plc is a United Kingdom-based liquid biopsy company. The Company is engaged in the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy-non-invasive cancer diagnostics. Its platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for highly multiplexed analysis of nucleic acids and proteins. Its Parsortix PC1 Clinical system captures and harvests circulating CTCs from metastatic breast cancer patients blood for subsequent, user-validated analysis. The Parsortix PC1 Clinical System is a liquid biopsy technology. Its labs in Guildford provide specialist CTC enrichment and analysis services to support translational research studies and pharmaceutical trials. It has developed the Parsortix system, including instruments and one-time use cassettes that can be sold to third-party laboratories for their use in research, pharmaceutical development, or clinical use.
Financial Summary
BRIEF: For the six months ended 30 June 2023, ANGLE plc revenues increased from £419K to £1.2M. Net loss increased 6% to £9.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Operating costs increase of 7% to £11.4M (expense), Other Operating Income decrease from £1K (income) to £0K. Basic Earnings per Share excluding Extraordinary Items remained flat at -£0.04.
Financials
Income Statement - All values are in GBP (M).
|
Year Ending |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
30/04/2019 |
30/04/2018 |
|---|---|---|---|---|---|---|
| Total Revenue | 1.04 | 1.01 | 0.76 | 0.58 | 0.68 | 0.63 |
| Gross profit | 0.16 | 0.18 | 0.24 | -0.01 | 0.24 | 0.46 |
| Operating Profit/Loss | -24.21 | -17.24 | -13.73 | -7.70 | -10.90 | -8.93 |
| Profit Before Tax | -24.44 | -17.36 | -13.75 | -7.73 | -10.87 | -8.93 |
| Profit After Tax | -21.69 | -15.01 | -11.61 | -6.25 | -8.93 | -7.54 |
| Equity Holders of Parent Company | -21.69 | -15.01 | -11.61 | -6.25 | -8.94 | -7.56 |
| Minority Interest | NIL | -0.66 | -0.02 | NIL | NIL | NIL |
Balance Sheet - All values are in GBP (M).
|
Year Ending |
31/12/2022 |
31/12/2021 |
31/12/2020 |
31/12/2019 |
30/04/2019 |
30/04/2018 |
|---|---|---|---|---|---|---|
| Total Non-Current Assets | 11.24 | 7.95 | 22.66 | 10.72 | 8.18 | 7.06 |
| Total Current Assets | 38.63 | 39.37 | 16.39 | 23.58 | 14.84 | 11.22 |
| Total Assets | 49.87 | 47.32 | 39.05 | 34.30 | 23.02 | 18.28 |
| Total Liabilities | 9.81 | 7.64 | 4.71 | 3.98 | 3.68 | 1.74 |
| Total Net Assets | 40.06 | 39.68 | 34.34 | 30.32 | 19.34 | 16.54 |
| Shareholders Funds | 40.06 | 40.33 | 34.34 | 30.32 | 19.34 | 16.54 |
| Minority Interests | NIL | -0.66 | -0.02 | NIL | NIL | NIL |
| Total Equity | 40.06 | 39.68 | 34.34 | 30.32 | 19.34 | 16.54 |
Outlook
Broker View
Data shown is based on the past 75 days of broker views.
|
ActionBrokers |
Strong Buy1 |
Buy0 |
Neutral0 |
Sell0 |
Strong Sell0 |
|---|---|---|---|---|---|
| Brokers | 1 | 0 | 0 | 0 | 0 |
| Consensus |
ConsensusStrong Buy |
||||
Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.
© 2022 Refinitiv, an LSEG business. All rights reserved.
Forecasts
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | £2.08mn | £6.67mn | £15.00mn |
| Pre-tax-Profit | -£20.65mn | -£13.97mn | -£11.00mn |
| EPS | -£0.07p | -£0.05p | -£0.04p |
| EPS Growth | 0.00% | 0.00% | 0.00% |
| P/E | -1.61 | -2.44 | -3.28 |
| PEG Ratio | 0.00 | 0.00 | 0.00 |
| Dividend | 0.00p | 0.00p | 0.00p |
| Yield | 0.00% | 0.00% | 0.00% |
Upgrades & Downgrades (Latest)
| Date | Broker | Recommendation | Price | Old Target | New Target | Change |
|---|---|---|---|---|---|---|
| 24th Apr 2024 | Berenberg Bank | Reiteration | 15p | 0p | 70p | Buy |
| 25th May 2023 | Berenberg Bank | Reiteration | 18p | 0p | 120p | Buy |
| 21st Apr 2023 | Berenberg Bank | Reiteration | 25p | 0p | 120p | Buy |
| 5th Jan 2023 | Berenberg Bank | Reiteration | 30p | 241p | 120p | Buy |
| 5th Aug 2022 | Berenberg Bank | Reiteration | 71p | 231p | 231p | Buy |
| 23rd May 2022 | Berenberg Bank | Reiteration | 99p | 0p | 195p | Buy |
| 13th May 2022 | Berenberg Bank | Reiteration | 103p | 0p | 195p | Buy |
| 28th Apr 2022 | Berenberg Bank | Reiteration | 102p | 0p | 195p | Buy |
Time & Sales
All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.
| Date | Time | Price | Volume | Type |
|---|---|---|---|---|
| 26 Apr 2024 | 16:29 | 14.25 | 50,000 | Sell |
| 26 Apr 2024 | 16:24 | 14.4 | 10,000 | Sell |
| 26 Apr 2024 | 16:08 | 14.1 | 28,151 | Sell |
| 26 Apr 2024 | 16:07 | 14 | 28,381 | Sell |
| 26 Apr 2024 | 15:58 | 14.4 | 436 | Sell |
| 26 Apr 2024 | 15:44 | 14.644 | 4,804 | Buy |
| 26 Apr 2024 | 14:35 | 14.66 | 283 | Buy |
| 26 Apr 2024 | 14:14 | 14.7 | 2,500 | Buy |
| 26 Apr 2024 | 13:44 | 14.74 | 20,000 | Buy |
| 26 Apr 2024 | 13:29 | 14.4 | 35 | Sell |
| 26 Apr 2024 | 13:29 | 14.75 | 20,000 | Buy |
| 26 Apr 2024 | 12:53 | 14.6515 | 30,000 | Buy |
| 26 Apr 2024 | 12:50 | 14.65 | 25,000 | Buy |
| 26 Apr 2024 | 12:49 | 14.5 | 30,000 | Unknown |
| 26 Apr 2024 | 12:21 | 14.875 | 3,000 | Buy |
| 26 Apr 2024 | 12:04 | 14.945 | 35 | Buy |
| 26 Apr 2024 | 11:38 | 14.899 | 6,711 | Buy |
| 26 Apr 2024 | 11:30 | 14.945 | 669 | Buy |
| 26 Apr 2024 | 10:55 | 14.88 | 8,000 | Buy |
Selected data supplied by Thomson Reuters © View restrictions.